Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Global health targets

Two million people with HIV started treatment in 2015

News
31 May 2016
PrEP

Further update on commissioning and provision of Pre Exposure Prophylaxis (PREP) for HIV prevention

Editor's pick
NHS England
31 May 2016
PrEP

Sex Without Shame – four men reveal how PrEP has changed their attitudes to sex, relationships and HIV

Editor's pick
Gay Times
31 May 2016
Government, leadership & policy

Rhetoric Versus Reality: Can the Next President 'End AIDS' in the United States?

Editor's pick
The Body
31 May 2016
Health monitoring in resource-limited settings

Very high levels of drug resistance seen in people experiencing first-line antiretroviral therapy failure in Kenya

News
31 May 2016
Smoking

World No Tobacco Day 2016: Living with HIV, dying with noncommunicable diseases (NCDs)

Editor's pick
Inis Communication
31 May 2016
Hepatitis C symptoms & diagnosis

Study Finds Patients with Hepatitis C Have Higher Hospitalization Rate

Editor's pick
MD Magazine
31 May 2016
Hepatitis C treatment

Washington Ordered to Cover Hepatitis C Drugs During Lawsuit

Editor's pick
Bloomberg
31 May 2016
Global health targets

New UN treatment targets for HIV/AIDS would be 'expensive but worth every penny'

Editor's pick
Eurekalert Inf Dis
31 May 2016
Hepatitis C treatment

Philippines FDA warns against fake Hepatitis C medicines

Editor's pick
GMA News
31 May 2016
Global health targets

Global AIDS Update 2016

Editor's pick
UNAIDS
31 May 2016
Global health targets

UNAIDS announces 2 million more people living with HIV on treatment in 2015, bringing new total to 17 million

Editor's pick
UNAIDS
31 May 2016
Pharmaceutical industry

A question of timing: A lawsuit claims Gilead Sciences could have developed a less-harmful version of its HIV treatment sooner

Editor's pick
Los Angeles Times
30 May 2016
New & experimental hepatitis C treatment

Merck Receives Positive CHMP Opinion for ZEPATIER™ (elbasvir and grazoprevir) in the European Union

Editor's pick
MSD press release
30 May 2016
PrEP

Every major UK HIV organisation calls on NHS to provide prevention drug

Editor's pick
BuzzFeed
28 May 2016
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

Editor's pick
Gilled press relase
27 May 2016
PrEP

Global call for PrEP access

Editor's pick
Positive Living
27 May 2016
Cancer

Anti-cancer jab piloted in gay men

Editor's pick
BBC
27 May 2016
Harm reduction

FDA approves first buprenorphine implant for treatment of opioid dependence

Editor's pick
FDA
27 May 2016
Chemsex & recreational drug use

Would you take a drug to prevent meth relapses, or stop alcohol cravings?

Editor's pick
BETA blog
27 May 2016
Side effects

Rare but severe liver side-effects reported among South African patients starting efavirenz-based ART

News
27 May 2016
PrEP

Cipla gets approval to sell its version of Truvada PrEP in India

Editor's pick
The Hindu Business Line
26 May 2016
Neurological & cognitive problems

HIV-positive women with childhood trauma have double the brain trouble

Editor's pick
The Conversation
26 May 2016
Sex workers

Decriminalising sex work the key to success of HIV programmes

Editor's pick
BDlive
26 May 2016